Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in pregnancies with insulin‐dependent diabetes: implications for screening for Down's syndrome
- 1 January 1992
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 99 (1), 51-53
- https://doi.org/10.1111/j.1471-0528.1992.tb14392.x
Abstract
Objective To investigate maternal serum unconjugated oestriol (uE3) and human chorionic gonadotrophin (hCG) levels in pregnant women with insulin‐dependent diabetes mellitus and to consider the implications of the results for antenatal screening for Down's syndrome. Design Descriptive study using stored antenatal serum samples. Setting Stored serum samples collected from women receiving routine antenatal care in Oxford. Subjects 126 singleton pregnancies in 92 women with insulin‐dependent diabetes mellitus and for each pregnancy, two pregnancies without diabetes matched for gestational age and duration of storage of the serum sample. None of the pregnancies was associated with fetal neural tube defect or Down's syndrome. Main study measures Maternal serum uE3 and hCG levels at 15–22 weeks gestation. Alpha‐fetoprotein (AFP) levels were also measured for comparison. Results The median uE3 level in the diabetic pregnancies was 0.92 multiples of the median (MoM) for pregnancies without diabetes at the same gestational age (PP=0.48). The median AFP level was also reduced to 0.77 MoM (P3 and AFP levels in insulin‐dependent diabetic pregnancies is sufficiently great to be taken into account in maternal serum screening programmes for Down's syndrome. Dividing the uE3 and AFP levels in such pregnancies by the corresponding median for insulin‐dependent diabetic pregnancies will yield a similar false‐positive rate in pregnancies with and without insulin‐dependent diabetes mellitus.Keywords
This publication has 15 references indexed in Scilit:
- Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's syndromeBJOG: An International Journal of Obstetrics and Gynaecology, 1991
- A longitudinal study of circulating progesterone, oestradiol, hCG and hPL during pregnancy in type 1 diabetic mothersBJOG: An International Journal of Obstetrics and Gynaecology, 1989
- Maternal serum screening for Down's syndrome in early pregnancy.BMJ, 1988
- MATERNAL SERUM ALPHA-FETOPROTEIN IN DIABETIC PREGNANCY: CORRELATION WITH BLOOD GLUCOSE CONTROLThe Lancet, 1987
- Prenatal diagnosis of neural tube defectsAmerican Journal of Obstetrics and Gynecology, 1982
- MATERNAL SERUM ALPHA‐FETOPROTEIN AND DIABETES MELLITUSBJOG: An International Journal of Obstetrics and Gynaecology, 1979
- PLASMA OESTRIOL IN PREGNANCY COMPLICATED BY DIABETES MELLITUSBJOG: An International Journal of Obstetrics and Gynaecology, 1973
- Prognostic value of human chorionic somatomammotropin plasma levels in diabetic patientsAmerican Journal of Obstetrics and Gynecology, 1973
- Patterns of Serum Immunoreactive Human Placental Lactogen (IR-HPL) and Chorionic Gonadotropin (IR-HCG) in Diabetic PregnancyDiabetes, 1971
- Plasma estriol levels in normal and abnormal pregnancies: An index of fetal welfareAmerican Journal of Obstetrics and Gynecology, 1968